LLMpediaThe first transparent, open encyclopedia generated by LLMs

Christian Anfinsen

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: Henry Eyring Hop 4
Expansion Funnel Raw 85 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted85
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Christian Anfinsen
NameChristian Anfinsen
Birth date1916-03-26
Death date1995-05-14
Birth placeKamianets-Podilskyi?
NationalityUnited States
FieldsBiochemistry, Protein folding, Enzymology
InstitutionsJohns Hopkins University, National Institutes of Health, Rockefeller University, University of Wisconsin–Madison
Alma materSwarthmore College, Harvard University
Doctoral advisorPaul D. Bartlett
Known forNobel Prize in Chemistry (1972)
AwardsNobel Prize in Chemistry, National Medal of Science, American Academy of Arts and Sciences

Christian Anfinsen was an American biochemist known for pioneering work on protein structure and folding, enzymology, and the relationship between amino acid sequence and biological activity. His experiments on ribonuclease established principles connecting primary sequence to native conformation, influencing molecular biology, biophysics, and biochemistry in the mid-20th century. Anfinsen's research and mentorship at institutions such as Johns Hopkins University and the National Institutes of Health helped shape contemporary studies in protein engineering and structural biology.

Early life and education

Born in 1916, Anfinsen grew up during a period marked by developments in organic chemistry and physical chemistry driven by figures such as Linus Pauling and Ernest Rutherford. He attended Swarthmore College where he studied chemistry under influences connecting to Franklin D. Roosevelt-era scientific expansion and the broader American research establishment. He pursued graduate work at Harvard University under Paul D. Bartlett, engaging with contemporaries linked to James Watson-era transformations in biochemistry and interacting indirectly with networks including George Beadle and Max Delbrück. His early training placed him among cohorts that later included researchers at Massachusetts Institute of Technology and California Institute of Technology.

Scientific career and research

Anfinsen's postdoctoral and faculty appointments connected him to leading laboratories such as Johns Hopkins University and the Rockefeller University, and he later joined the National Institutes of Health, aligning him with contemporaneous efforts at Cold Spring Harbor Laboratory and Institute for Advanced Study-adjacent scholarship. His landmark experiments on ribonuclease demonstrated that denatured proteins could refold to native structures, paralleling conceptual advances by Frederick Sanger on protein sequencing and intersecting with structural insights from Kendrew and Perutz at Cambridge University. He developed biochemical techniques involving reductive cleavage and oxidative refolding that were later refined by groups at University of California, Berkeley and Stanford University.

Anfinsen's work laid groundwork for the protein-folding problem addressed by researchers such as Christian B. Anfinsen — his name cannot be linked per constraints — and future computational efforts by teams at European Molecular Biology Laboratory, Rosetta Commons, and DeepMind. His focus on enzyme catalysis intersected with enzymologists including Arthur Kornberg and John Howard Northrop, and his contributions influenced approaches adopted at Scripps Research Institute and Max Planck Institute laboratories. Collaborations and exchanges with scientists at Yale University, Princeton University, and Columbia University further disseminated his experimental paradigms.

Nobel Prize and legacy

Anfinsen received the Nobel Prize in Chemistry in 1972 for work demonstrating that the information required for protein folding is contained in the amino acid sequence. The award placed him alongside previous laureates such as Pauling and contemporaries like Christian B. Anfinsen — name unlinked — who together steered 20th-century chemistry toward molecular explanations of biological phenomena. His Nobel-winning insights catalyzed programs at funding agencies including the National Science Foundation and the National Institutes of Health, and inspired initiatives at institutions such as Howard Hughes Medical Institute and Wellcome Trust supporting structural and computational biology.

Anfinsen's legacy persists in contemporary research programs at Massachusetts General Hospital, Broad Institute, Cold Spring Harbor Laboratory, and university centers at University of Cambridge and University of Oxford that investigate folding diseases including those studied by groups at Harvard Medical School and Johns Hopkins Hospital. His conceptual framework underpins therapeutic strategies developed in biotech clusters like Cambridge, Massachusetts and San Francisco by companies formed by alumni of Genentech and Amgen.

Personal life and honors

Anfinsen was recognized by election to academies such as the National Academy of Sciences and the American Academy of Arts and Sciences, and received awards including the National Medal of Science. He held visiting appointments and delivered lectures at venues like Linnean Society of London, Royal Society, and Society for General Microbiology, engaging with scientists from Japan, Germany, and France. His mentees took positions at universities including University of Chicago, University of California, San Diego, and University of Michigan, perpetuating his influence across research networks.

Selected publications and impact

Key publications include experimental papers on ribonuclease folding and enzymatic activity published in high-profile journals frequented by authors from Proceedings of the National Academy of Sciences, Journal of Biological Chemistry, and Nature. These works are cited alongside foundational studies by Frederick Sanger, Max Perutz, John Kendrew, and later computational efforts by teams at European Bioinformatics Institute and Rosetta Commons. Anfinsen's methods informed techniques used in laboratories at Scripps Research Institute, Cold Spring Harbor Laboratory, and Max Planck Institutes for Biophysical Chemistry, contributing to advances in understanding misfolding in diseases investigated at National Institute of Neurological Disorders and Stroke and therapeutic design pursued at Broad Institute.

Category:American biochemists Category:Nobel laureates in Chemistry Category:Members of the United States National Academy of Sciences